검색어: hairy cell (영어 - 몰타어)

hairy cell leukaemia
lewkimja tal-hairy cell

andean hairy armadillo
armadillo muxgħar tal-andi

treatment of patients with hairy cell leukaemia.
il-kura ta’ pazjenti bil-lewkimja tal-hairy cell.

mexican hairy dwarf porcupine
porkuspin nanu muswaf messikan

northern hairy-nosed wombat
wombat imnieħru muxgħar tat-tramuntana

litak is indicated for the treatment of hairy cell leukaemia.
litak huwa indikat għat-trattament ta’ lewkimja tac-ċelluli ċiljati (‘hairy cell leukaemia’).

secondary malignancies are expected to occur in patients with hairy cell leukaemia.
malinni sekondarji huma mistennija li jseħħu f’pazjenti li għandhom lewkimja taċ-ċelluli ċiljati (‘hairy cell leukaemia’).

litak has been examined in one main study involving 63 patients with hairy cell leukaemia.
litak ġie eżaminat fi studju wieħed ewlieni bis- sehem ta ’ 63 pazjent bil- lewċemija taċ- ċelloli tax - xagħar.

high doses of co-trimoxazole, an antibiotic cladribine, used to treat hairy cell leukaemia
dożi għolja ta’ co-trimoxazole, antibijotiku cladribine, użata biex tikkura l-lewkimja taċ-ċelluli ċiljati

high doses of trimethoprim/sulfamethoxazole, an antibiotic cladribine, used to treat hairy cell leukaemia
dożi għolja ta’ trimethoprim/sulfamethoxazole, anti-bijotiku cladribine, użata biex tikkura l-lewkimja taċ-ċelluli ċiljati

forty-three percent of patients with hairy cell leukaemia experienced infectious complications at standard dose regimen.
tlieta u erbgħin fil-mija tal-pazjenti b’lewkimja taċ-ċelluli ċiljati kellhom komplikazzjonijiet infettivi bir-reġimen ta’ doża stàndard.

high doses of co-trimoxazole, an antibiotic. cladribine (used to treat hairy cell leukaemia).
dożi għoljin ta’ co-trimoxazole, antibijotiku. cladribine (użat għall-kura ta’ lewkimja ta’ ċelloli sufin).

cladribine, used to treat hairy cell leukaemia rifampicin, to treat tuberculosis (tb) and other bacterial infections
cladribine, użat għat-trattament ta’ lewkimja ta’ ċelloli ċiljati rifampicin, użat għat-trattament ta’ tuberkolożi (tb) u infezzjonijiet batterjali oħrajn

 235 most patients with hairy cell leukaemia, normalisation of one or more haematological variables occurs within one to two months of introna treatment.
fil- biċċa l- kbira tal- pazjenti bil- lewkimja tal- hairy cell, in- normalizzazzjoni ta ’ kwantità varjabbli ematoloġika waħda jew aktar isseħħ fi żmien xahar sa xahrejn tat- trattament b’ introna.

cladribine – used to treat hairy cell leukaemia. antacids containing aluminium and/or magnesium – used for heartburn.
cladribine – użat biex jikkura lewkimja tal-‘hairy cell’. antaċidi li fihom aluminju u/jew manjeżju - użati għal ħruq ta’ stonku.

included are hairy cell leukaemia, chronic myelogenous leukaemia, multiple myeloma, follicular lymphoma, carcinoid tumour, and malignant melanoma.
inklużi hemm il- lewkimja tal-hairy cell, lewkimja tal-mudullun kronika, majeloma multipla, limfoma follikulari, tumur karċinojde u melanoma malinna.

lychee (litchi) (pulasan, rambutan (hairy litchi), mangosteen)
liċċi (lychee) (pulasan, rambutan (liċċi bis-suf), mangosteen)

the term ‘hairy cell’ refers to the hair-like projections that can be seen on the surface of the lymphocytes when they are examined under a microscope.
it-terminu ‘ċelloli bix-xagħar’ jirreferi għal projezzjonijiet qishom xagħar li jidhru fuq l-uċuh tal-linfoċiti meta dawn jiġu eżaminati taħt mikroskopju.

the committee for medicinal products for human use (chmp) decided that litak’s benefits are greater than its risks for the treatment of hairy cell leukaemia.
il-kumitat għall-prodotti mediċinali għall-użu mill-bniedem (is-chmp) iddeċieda li l-benefiċċji ta’ litak huma ikbar mir-riskji tiegħu għat-trattament tal-lewċemija taċ-ċelloli bix-xagħar.

acute, irreversible neuro- and nephrotoxicity have been described in individual patients treated at a dose which was ≥ 4 times higher than the recommended regimen for hairy cell leukaemia.
newro- u nefro-tossiċità akuta irriversibbli, ġew deskritti f’pazjenti individwali ttrattati b’doża li kienet ≥ 4 aktar mir-reġimen rakkomandat għal- lewkimja taċ-ċelluli ċiljati.